In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
August 16th, 2004 | 21 | Yes |
1-(tert-Butyl)-3-(4-chlorophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 3.23 | 8.55 | -7.31 | 2 | 5 | 0 | 70 | 301.781 | 2 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
ALOGPS_SOLUBILITY | 2.03e-02 g/l | DrugBank-experimental |
Target | Src | Selleck Chemicals |
Indications | Src family tyrosine kinase inhibitor | KeyOrganics Bioactives |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
ABL1-1-E | Tyrosine-protein Kinase ABL (cluster #1 Of 1), Eukaryotic | Eukaryotes | 500 | 0.42 | Binding ≤ 10μM |
EGFR-1-E | Epidermal Growth Factor Receptor ErbB1 (cluster #1 Of 4), Eukaryotic | Eukaryotes | 480 | 0.42 | Binding ≤ 10μM |
HCK-1-E | Tyrosine-protein Kinase HCK (cluster #1 Of 1), Eukaryotic | Eukaryotes | 5 | 0.55 | Binding ≤ 10μM |
KC1D-1-E | Casein Kinase I Delta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 41 | 0.49 | Binding ≤ 10μM |
LCK-1-E | Tyrosine-protein Kinase LCK (cluster #1 Of 4), Eukaryotic | Eukaryotes | 31 | 0.50 | Binding ≤ 10μM |
RIPK2-1-E | Serine/threonine-protein Kinase RIPK2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 19 | 0.51 | Binding ≤ 10μM |
SRC-1-E | Tyrosine-protein Kinase SRC (cluster #1 Of 3), Eukaryotic | Eukaryotes | 500 | 0.42 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
KC1D_HUMAN | P48730 | Casein Kinase I Delta, Human | 41 | 0.49 | Binding ≤ 1μM |
EGFR_HUMAN | P00533 | Epidermal Growth Factor Receptor ErbB1, Human | 480 | 0.42 | Binding ≤ 1μM |
RIPK2_HUMAN | O43353 | Serine/threonine-protein Kinase RIPK2, Human | 19 | 0.51 | Binding ≤ 1μM |
ABL1_HUMAN | P00519 | Tyrosine-protein Kinase ABL, Human | 500 | 0.42 | Binding ≤ 1μM |
HCK_HUMAN | P08631 | Tyrosine-protein Kinase HCK, Human | 5 | 0.55 | Binding ≤ 1μM |
LCK_MOUSE | P06240 | Tyrosine-protein Kinase LCK, Mouse | 31 | 0.50 | Binding ≤ 1μM |
LCK_HUMAN | P06239 | Tyrosine-protein Kinase LCK, Human | 4 | 0.56 | Binding ≤ 1μM |
SRC_HUMAN | P12931 | Tyrosine-protein Kinase SRC, Human | 50 | 0.49 | Binding ≤ 1μM |
SRC_CHICK | P00523 | Tyrosine-protein Kinase SRC, Chick | 36 | 0.50 | Binding ≤ 1μM |
KC1D_HUMAN | P48730 | Casein Kinase I Delta, Human | 41 | 0.49 | Binding ≤ 10μM |
EGFR_HUMAN | P00533 | Epidermal Growth Factor Receptor ErbB1, Human | 480 | 0.42 | Binding ≤ 10μM |
RIPK2_HUMAN | O43353 | Serine/threonine-protein Kinase RIPK2, Human | 19 | 0.51 | Binding ≤ 10μM |
ABL1_HUMAN | P00519 | Tyrosine-protein Kinase ABL, Human | 500 | 0.42 | Binding ≤ 10μM |
HCK_HUMAN | P08631 | Tyrosine-protein Kinase HCK, Human | 5 | 0.55 | Binding ≤ 10μM |
LCK_MOUSE | P06240 | Tyrosine-protein Kinase LCK, Mouse | 31 | 0.50 | Binding ≤ 10μM |
LCK_HUMAN | P06239 | Tyrosine-protein Kinase LCK, Human | 4 | 0.56 | Binding ≤ 10μM |
SRC_HUMAN | P12931 | Tyrosine-protein Kinase SRC, Human | 2800 | 0.37 | Binding ≤ 10μM |
SRC_CHICK | P00523 | Tyrosine-protein Kinase SRC, Chick | 36 | 0.50 | Binding ≤ 10μM |
Description | Species |
---|---|
activated TAK1 mediates p38 MAPK activation | |
ADP signalling through P2Y purinoceptor 1 | |
c-src mediated regulation of Cx43 function and closure of gap junctions | |
CD28 co-stimulation | |
CD28 dependent PI3K/Akt signaling | |
CD28 dependent Vav1 pathway | |
CDO in myogenesis | |
Circadian Clock | |
Constitutive PI3K/AKT Signaling in Cancer | |
CTLA4 inhibitory signaling | |
DAP12 signaling | |
DCC mediated attractive signaling | |
Downstream signal transduction | |
Downstream TCR signaling | |
DSCAM interactions | |
EGFR downregulation | |
EGFR interacts with phospholipase C-gamma | |
EGFR Transactivation by Gastrin | |
EPH-ephrin mediated repulsion of cells | |
EPH-Ephrin signaling | |
EPHA-mediated growth cone collapse | |
EPHB-mediated forward signaling | |
Ephrin signaling | |
Factors involved in megakaryocyte development and platelet production | |
FCGR activation | |
GAB1 signalosome | |
Generation of second messenger molecules | |
GP1b-IX-V activation signalling | |
GPVI-mediated activation cascade | |
GRB2 events in EGFR signaling | |
GRB2 events in ERBB2 signaling | |
GRB2:SOS provides linkage to MAPK signaling for Integrins | |
Integrin alphaIIb beta3 signaling | |
Interleukin-1 signaling | |
Interleukin-2 signaling | |
JNK (c-Jun kinases) phosphorylation and activation mediated by activated human | |
Loss of Nlp from mitotic centrosomes | |
Loss of proteins required for interphase microtubule organization from the ce | |
NCAM signaling for neurite out-growth | |
Nef and signal transduction | |
Nef Mediated CD4 Down-regulation | |
Netrin mediated repulsion signals | |
NOD1/2 Signaling Pathway | |
p130Cas linkage to MAPK signaling for integrins | |
p38MAPK events | |
p75NTR recruits signalling complexes | |
PD-1 signaling | |
PECAM1 interactions | |
Phosphorylation of CD3 and TCR zeta chains | |
PI3K events in ERBB2 signaling | |
PIP3 activates AKT signaling | |
PLCG1 events in ERBB2 signaling | |
Recruitment of mitotic centrosome proteins and complexes | |
Regulation of actin dynamics for phagocytic cup formation | |
Regulation of KIT signaling | |
Regulation of PLK1 Activity at G2/M Transition | |
Regulation of signaling by CBL | |
Role of Abl in Robo-Slit signaling | |
SHC1 events in EGFR signaling | |
SHC1 events in ERBB2 signaling | |
Signal regulatory protein (SIRP) family interactions | |
Signal transduction by L1 | |
Signaling by constitutively active EGFR | |
Signaling by EGFR | |
Signaling by ERBB2 | |
Signaling by ERBB4 | |
Signaling by SCF-KIT | |
TAK1 activates NFkB by phosphorylation and activation of IKKs complex | |
Thrombin signalling through proteinase activated receptors (PARs) | |
Translocation of ZAP-70 to Immunological synapse | |
VEGFA-VEGFR2 Pathway | |
VEGFR2 mediated cell proliferation |
No pre-computed analogs available. Try a structural similarity search.